Return to results
Journal articles (2007), European Journal of Endocrinology, 156 (5), pp. 531-538

Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal

de Pouvourville Gérard , Borget Isabelle, Corone Carine, Nocaudie Marie, Allyn Mark

The prescription of the recombinant human TSH, Thyrogen, during the follow-up controls for patients treated for thyroid cancer significantly reduces the number and the duration of sikleave days when compared to traditional thyroid hormone withdrawal.

DE POUVOURVILLE, G., BORGET, I., CORONE, C., NOCAUDIE, M. and ALLYN, M. (2007). Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal. European Journal of Endocrinology, 156(5), pp. 531-538.

Keywords : #productivity, #thyroid-cancer.